Welcome to the e-CCO Library!

P467: Perception Gap between Patients with Inflammatory Bowel Disease (IBD) and Physicians in China: A Cross-sectional Study
Year: 2021
Source: ECCO'21 Virtual
Authors: Liang , J.(1);Cao , Q.(2);Chen , M.(3);Wu , K.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P467: The validation of the Crohn’s and Ulcerative Colitis Questionnaire–12 Plus (CUCQ-12 plus): a short quality-of-life measure for inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Shwana*1, L. Alrubaiy1, H. Hutchings2, J. Williams2, A. Protheroe3, K. Mortier4

Created: Friday, 22 February 2019, 9:49 AM
P467: Therapeutic drug monitoring of biologics in Inflammatory Bowel Disease: Nordic survey on implementation and barriers in clinical practice
Year: 2022
Source: ECCO'22
Authors: Bjørlykke, K.(1);Jahnsen, J.(1);Brynskov, J.(2);Molander, P.(3);Eberhardson, M.(4);Davidsdottir, L.G.(5);Sipponen, T.(3);Hjortswang, H.(4);Langholz, E.(2);Jørgensen, K.K.(1);Steenholdt, C.(2);
Created: Friday, 11 February 2022, 3:52 PM
P468 Switching from adalimumab originator to ABP 501 biosimilar: a multicentre North Italian study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

B. Barberio1, P. Melatti1, F. Zingone1, L. Bertani2, A. Ferronato3, A. GUBBIOTTI1, D. Massimi4, R. D’Incà1, E.V. Savarino5

Created: Thursday, 30 January 2020, 10:12 AM
P468: Analysis of international spontaneous reporting system databases for safety of corticosteroids in Inflammatory Bowel Disease: The Determinants, Incidence and consequences of Corticosteroid Excess (DICE)-impact study
Year: 2021
Source: ECCO'21 Virtual
Authors: Raine, T.(1);Bokemeyer, B.(2);Finney-Hayward, T.(3);Munsaka, M.(4);Liu, M.(4);Louis, E.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P468: Association of uncontrolled disease with quality of life and healthcare resource utilisation in Ulcerative Colitis patients treated with advanced therapy in the United States
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Igho-Osagie, E.(1);Knight, H.(2);Barlow, S.(3);Harvey, N.(2);Khandker, R.(1)*;
Created: Friday, 14 July 2023, 11:05 AM
P468: Etrolizumab treatment improves histological activity as assessed by the Robarts histopathology index
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Feagan B.G.1, De Hertogh G.2, Peyrin-Biroulet L.3, Rubin D.T.4, Maciuca R.5, McBride J.5, Arulmani U.*5, Scherl A.5

Created: Wednesday, 20 February 2019, 10:36 AM
P468: Evaluation of work productivity and activity impairment in moderate-to-severe ulcerative colitis participants treated with ozanimod in the phase 3 True North study
Year: 2022
Source: ECCO'22
Authors: Floden, L.(1);Pham, T.P.(2);Kumar, J.(3);Becker, B.(3);Shaw, J.W.(3);Tencer, T.(3);
Created: Friday, 11 February 2022, 3:52 PM
P468: Long-term efficacy and safety of thiopurine in biologic-naïve Japanese patients with ulcerative colitis: a multicentre retrospective study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

T. Takagi*1, M. Matsuura2, S. Yamada2, S. Bamba3, Y. Hotta1, K. Uchiyama1, Y. Naito1, H. Nakase2, A. Andoh3, T. Kawamura4, S. Katsushima5, T. Kusaka6, H. Obata7, T. Kogawa8

Created: Friday, 22 February 2019, 9:49 AM
P468: Long-term function after transanal vs. transabdominal ileal pouch-anal anastomosis for ulcerative colitis: a multi-centre cohort study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Chandrasinghe1, M. Carvello2, K. Wasmann3, P. Tanis3, J. Warusavitarne5, A. Spinelli*2, W. Bemelman3

Created: Friday, 22 February 2019, 9:41 AM
P468: Microscopic colitis: systematic analysis of 200 adult patients with a mean follow-up of 4 years
Year: 2018
Source: ECCO '18 Vienna
Authors:

H. Maye1*, E. Safroneeva2, S. Godat1, A. Schoepfer1

Created: Thursday, 21 February 2019, 9:14 AM
P469 Stay in class or switch out of class after anti-TNF failure in inflammatory bowel disease (IBD). Real-world data from a large district general hospital
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H. Johnson, S. Vythilingam, S. McLaughlin

Created: Thursday, 30 January 2020, 10:12 AM
P469: Changes in peripheral blood lymphocyte subsets induced by azathioprine in Crohn’s disease patients
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Labidi*, M. Fekih, N. Ben Mustapha, S. Ben Amor, M. Serghini, L. Kallel, J. Boubaker, A. Filali

Created: Friday, 22 February 2019, 9:49 AM
P469: Effect of mirikizumab on clinical and endoscopic outcomes based on prior advanced therapy failure in patients with moderately to severely active ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Navabi, S.(1)*;D'Haens, G.(2);Samaan, K.H.(3);Li, X.(3);Arora, V.(3);Redondo, I.(3);Danese, S.(4);
Created: Friday, 14 July 2023, 11:05 AM
P469: Effectiveness of dose optimisation by pre-genotyping NUDT 15 R139C on reducing thiopurine-induced leucopoenia in Chinese patients with Crohn’s disease: a randomised controlled trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Chao*1, L. Lin1, Y. Huang2, C. Zhang3, J. Huang1, Q. Cao2, X. Gao1, K. Chao1

Created: Friday, 22 February 2019, 9:41 AM
P469: Infliximab for induction of medically-induced remission in Crohn's disease: a Cochrane systematic review
Year: 2022
Source: ECCO'22
Authors: Radford, S.(1);Sinopoulou, V.(2);Gordon, M.(2);Eldragini, M.E.A.A.(1);Darie, A.M.(1);Akobeng, A.(3);Moran, G.W.(1);
Created: Friday, 11 February 2022, 3:52 PM
P469: Safety, tolerability, and pharmacokinetics of the intestine-restricted oral pan-Janus kinase inhibitor TD-1473 after single and multiple oral doses in healthy subjects
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ferslew B.*1, Sherman C.2, Nguyen D.3, Graham R.1

Created: Wednesday, 20 February 2019, 10:36 AM
P469: Self-reported cutaneous side effects of anti-TNF therapy in inflammatory bowel disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Ridge1*, C. Gallagher2, C. Judge1, J. Campion1, D. Mc Namara2,3,4, D. Kevans1,3,4

Created: Thursday, 21 February 2019, 9:14 AM
P469: The PROPER study: interim analysis of a pan-European real-world study of SB5 adalimumab biosimilar after transition from reference adalimumab in patients with Crohn’s disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Dignass, A.(1);Gisbert, J.(2);Freudensprung, U.(3);Addison, J.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P470 The concept of illness identity in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L.L. Knödler1, A. Thomann2, M.P. Ebert2, S. Lis3, W. Reindl2

Created: Thursday, 30 January 2020, 10:12 AM